Clinical Trials Logo

Clinical Trial Summary

This retrospective cohort study aims to investigate the effects of recombinant human growth hormone (rh-GH) on the euploid status of preimplantation blastocysts in AMA patients. Infertile patients aged 38-46 years old were recruited for study if they fulfill the inclusion criteria and do not have the exclusion criteria. Treatment group: Women received growth hormone (GH) supplement during antagonist protocol for ovarian stimulation. Control group: Women received antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts per stimulation cycle and per testing cycle.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05574894
Study type Interventional
Source ShangHai Ji Ai Genetics & IVF Institute
Contact
Status Completed
Phase Phase 3
Start date January 1, 2021
Completion date September 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT04079010 - The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone N/A
Completed NCT01540773 - Single Low-Dose of Supplement Amino Acid N/A
Completed NCT00562796 - Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity N/A
Completed NCT01158612 - The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella N/A
Recruiting NCT05447208 - Effect of GH on the Blastocyst Euploid Rate in AMA Patients Phase 3
Completed NCT00966134 - Ghrelin, Growth Hormone and Growth Factors at High Altitude N/A
Active, not recruiting NCT06433375 - Evaluation of the Efficacy of Growth Hormone on Healing of Periapical Pathosis N/A